​

CureVac (CVAC) Stock Forecast, Price Target & Predictions

OverviewOwnershipChartTranscripts

CVAC Stock Forecast

CureVac (CVAC) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $29.00, with a high of $37.00 and a low of $21.00. This represents a 417.86% increase from the last price of $5.60.

- $8 $16 $24 $32 $40 High: $37 Avg: $29 Low: $21 Last Closed Price: $5.6

CVAC Stock Rating

CureVac stock's rating consensus is Hold, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (42.86%), 4 Hold (57.14%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 7 0 4 3 Strong Sell Sell Hold Buy Strong Buy

CVAC Price Target Upside V Benchmarks

TypeNameUpside
StockCureVac417.86%
SectorHealthcare Stocks 24.81%
IndustryBiotech Stocks 65.78%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$5.60$5.60$5.60
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25122-16
May, 25122-16
Apr, 25122-16
Mar, 25132-17
Feb, 25132-17
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 07, 2023Eun YangJefferies$21.00$8.26154.24%275.00%
Apr 22, 2022JMP Securities$37.00$16.79120.37%560.71%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 07, 2023JefferiesBuyupgrade
Nov 17, 2022JMP SecuritiesMarket OutperformMarket Outperformhold

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.98$-2.21$-1.32------
Avg Forecast$-2.36$-3.23$-0.92$-0.71$0.79$-0.51$-0.28$-0.36$-0.20
High Forecast$-2.09$-2.86$-0.84$-0.46$0.86$0.16$-0.13$-0.17$-0.10
Low Forecast$-2.62$-3.59$-1.01$-0.96$0.72$-0.99$-0.43$-0.56$-0.31
Surprise %-58.47%-31.58%43.48%------

Revenue Forecast

$0 $110M $220M $330M $440M $550M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$48.90M$102.99M$67.42M$52.70M-----
Avg Forecast$71.41M$66.32M$60.96M$55.27M$517.95M$65.31M$135.75M$149.75M$144.69M
High Forecast$77.64M$72.11M$65.39M$77.58M$525.69M$91.68M$190.55M$210.20M$203.10M
Low Forecast$65.18M$60.53M$56.83M$32.95M$510.21M$38.94M$80.94M$89.28M$86.27M
Surprise %-31.52%55.28%10.60%-4.66%-----

Net Income Forecast

$-800M $-600M $-400M $-200M $0 $200M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-129.07M$-411.72M$-249.03M------
Avg Forecast$-520.52M$-712.84M$-202.82M$-157.57M$175.13M$-112.69M$-62.23M$-80.44M$-44.69M
High Forecast$-461.44M$-631.94M$-184.94M$-102.21M$189.73M$34.67M$-29.57M$-38.22M$-21.23M
Low Forecast$-579.58M$-793.73M$-222.00M$-212.93M$158.11M$-219.60M$-94.89M$-122.65M$-68.14M
Surprise %-75.20%-42.24%22.79%------

CVAC Forecast FAQ

Is CureVac stock a buy?

CureVac stock has a consensus rating of Hold, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 4 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that CureVac is a neutral investment for most analysts.

What is CureVac's price target?

CureVac's price target, set by 7 Wall Street analysts, averages $29 over the next 12 months. The price target range spans from $21 at the low end to $37 at the high end, suggesting a potential 417.86% change from the previous closing price of $5.6.

How does CureVac stock forecast compare to its benchmarks?

CureVac's stock forecast shows a 417.86% upside, outperforming the average forecast for the healthcare stocks sector (24.81%) and outperforming the biotech stocks industry (65.78%).

What is the breakdown of analyst ratings for CureVac over the past three months?

  • June 2025: 16.67% Strong Buy, 33.33% Buy, 33.33% Hold, 0% Sell, 16.67% Strong Sell.
  • May 2025: 16.67% Strong Buy, 33.33% Buy, 33.33% Hold, 0% Sell, 16.67% Strong Sell.
  • April 2025: 16.67% Strong Buy, 33.33% Buy, 33.33% Hold, 0% Sell, 16.67% Strong Sell.

What is CureVac’s EPS forecast?

CureVac's average annual EPS forecast for its fiscal year ending in December 2024 is $0.79, marking a 0% decrease from the reported $0 in 2023. Estimates for the following years are $-0.51 in 2025, $-0.28 in 2026, $-0.36 in 2027, and $-0.2 in 2028.

What is CureVac’s revenue forecast?

CureVac's average annual revenue forecast for its fiscal year ending in December 2024 is $517.95M, reflecting a 882.88% increase from the reported $52.7M in 2023. The forecast for 2025 is $65.31M, followed by $135.75M for 2026, $149.75M for 2027, and $144.69M for 2028.

What is CureVac’s net income forecast?

CureVac's net income forecast for the fiscal year ending in December 2024 stands at $175.13M, representing a 0% decrease from the reported $0 in 2023. Projections indicate $-113M in 2025, $-62.233M in 2026, $-80.441M in 2027, and $-44.688M in 2028.